Management of perianastomotic stenosis of direct wrist autogenous radial-cephalic arteriovenous accesses for dialysis  by Long, Bertrand et al.
Management of perianastomotic stenosis of direct
wrist autogenous radial-cephalic arteriovenous
accesses for dialysis
Bertrand Long, MD,a,f Nicolas Brichart, MD,a,f Patrick Lermusiaux, PhD,c,f
Luc Turmel-Rodrigues, MD,d Bernard Artru, MD,g Jean Michel Boutin, MD,a Josette Pengloan, MD,b
Philippe Bertrand, MD,e,f and Franck Bruyère, MD,a,f Tours and Le Mans, France
Objective:Radial-cephalic fistulas (RCFs) perianastomotic stenoses (PASs) are on and around the fistula anastomosis. This
group of lesions encompasses juxta-anastomotic stenosis (stenosis located on the venous side within 3 cm away from the
anastomosis), anastomotic, and arterial stenosis. The purpose of our study was to assess the postintervention primary
patency and assisted postintervention primary patency (APP) rates for surgery and angioplasty when treating these
stenoses. The secondary endpoint was to identify factors that might influence the procedure’s patency rates.
Materials and Methods: This retrospective study included 73 consecutive patients treated for lack of maturation PASs
between January 1999 and December 2005 in two interventional centers. Patients’ mean age was 65 years old. Stenoses
were treated by surgery (n  21) or percutaneous transluminal angioplasty (PTA; n  52). Surgery meant creation of a
new anastomosis excluding the area of stenosis. Preoperative characteristics including the patient’s age, gender,
comorbidities, stenosis location, and length were not statistically different between the two groups. The mean follow-up
was 39 months for PTA and 49 months for surgery.
Results: Anatomical and clinical success rates were 86% and 90% for surgery, and 75% and 92% for PTA. At 1 year, the
primary patency rates were 71  10% for surgery and 41  6% for PTA, respectively (P < .02). There was no significant
difference between the two groups with respect to assisted primary patency (95% vs 92%). In the PTA group, stenosis
location at the anastomosis itself was a risk factor of early recurrence (P  .047). The complication rate was similar
between surgery and PTA.
Conclusion: Our results suggest that the treatment of anastomotic stenoses should be surgical rather than endovascular.
Angioplasty and surgery have shown similar results when used to treat other perianastomotic stenoses, but repeat
procedures were more frequent with angioplasty. ( J Vasc Surg 2011;53:108-14.)The Kidney Disease Outcomes Quality Initiative1 and
the recent clinical practice guidelines of the American So-
ciety for Vascular Surgery2 recommend creation of autog-
enous fistulas before placement of prosthetic bridge grafts
or use of a central venous catheter for renal dialysis in view
of superior patency rates and lower rates of complications
once matured.
In 41% to 64% of cases, the stenosis complicating
autogenous radial-cephalic fistulas (RCFs) have a perianas-
tomotic site.3-6 Surgical treatment (redo RCF) by creation of
a new and slightly more proximal anastomosis was historically
the first available treatment and many authors still consider
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108that this is still preferable in this location.7-9 These stenoses
can also be treated by percutaneous transluminal angioplasty
(PTA) whose main advantages are usually a better preserva-
tion of the venous capital, immediate availability of the
fistula for dialysis, and a slightly less invasive nature.
Although many studies have reported the results of
angioplasty or surgery in the management of failing
RCFs in various clinical settings (thrombosis, stenosis,
and nonmaturation),3-5,8,10-17 few studies have specifically
evaluated these anastomotic stenoses.4,18 Only one non-
randomized study really did compare surgerywith angioplasty
for the treatment of juxta-anastomotic stenoses and con-
cluded far significantly better primary patency with surgery.19
The purpose of the present study was to determine the
postoperative primary patency (PP) and assisted postoper-
ative primary patency (APP) rates of surgery and angio-
plasty for the treatment of perianastomotic stenosis occur-
ring in distal RCF arteriovenous fistulas. The secondary
purpose was to identify factors that may impact the results.
MATERIALS AND METHODS
Population. This retrospective study included all pa-
tients referred for treatment of a perianastomotic stenosis
(PASs) of their distal autogenous RCFs in one surgical and
one radiological center between 1999 and 2005. Throm-
bosed fistulas, composite RCFs, RCFs in the upper fore-
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cally revised were excluded from the study.
Stenosis was defined as a more than 50% narrowing in
the luminal diameter based on comparison with the adja-
cent normal vessel. The degree of stenosis was measured
using a calibrated computer software (General Electric,
Milwaukee, Wis) .
This group of lesions (Fig 1) encompassed venous
stenosis (stenosis sitting on the venous side within 3 cm
from the anastomosis), anastomotic stenosis, and arterial
stenosis (stenosis located on the artery within 3 cm of the
anastomosis).
Vascular-access monitoring program. A program of
vascular-access monitoring detected stenoses. In patients
not dialyzed (n  5), the monitoring of the vascular access
combined physical examination and repeat Doppler ultra-
sound scan calculation of fistula flow rates. For patients on
dialysis, the monitoring of the vascular access combined
physical examination and monthly determinations of fistula
flow rate by the ultrasound scan dilution method: Tran-
sonic System HD01 (Transonic Systems Inc, Ithaca,
NY).20 Routine surveillance of fistulas in patients currently
on dialysis was not enforced at the time of the study in the
referring centers. Indications for imaging and stenosis re-
pair were clinically evident access dysfunction (difficulties in
cannulation, vacuum phenomenon during dialysis), access
flow (Qa)600 mL/mn or a decrease by20% in flow.21
Treatment of perianastomotic stenoses. For histor-
ical reasons, treatment was allocated differently depending
on the city of patient inclusion. In one center, the cases of
PAS were referred to the radiologist who conducted diag-
Fig 1. Peri-anastomotic stenoses - (a) venous stenosis, (b) anas-
tomotic stenosis, (c) arterial stenosis.nostic angiographic evaluation, then dilated the stenosis, orsuggested surgical treatment. In the other center, the vas-
cular surgeon conducted angiographic evaluation and con-
comitant surgical or endovascular treatment.
Surgical treatment was implemented using the tech-
nique described byOakes et al.11 Briefly, using clamps or an
inflatable tourniquet, a new side-to-end anastomosis was
performed a few centimeters proximal to the previous one.
A 7/0 polypropylene running suture was used and the
length of the anastomosis was 8 mm. No completion
angiography was performed. No interposition of prosthetic
material was ever performed.
The endovascular treatment (Fig 2) was conducted
after the patient was given local anesthesia using the tech-
nique reported by Turmel-Rodrigues et al.16 Angiography
was performed after retrograde puncture of the brachial
artery at the elbow or by retrograde cannulation of the
arterialized vein after placement of a tourniquet in the
upper arm and advancing a 4F catheter to the anastomosis.
For the dilation stage, a retrograde venous approach was
used in all cases. The stenosis was passed using either a
0.035” hydrophilic wire or a 0.014” wire in cases of tight
heterogeneous lesions. Ideally, a wire was advanced
through the anastomosis into the proximal radial artery and
another wire was advanced into the distal artery. The guide-
wire placed into the distal radial artery was used for dilation
of purely venous stenosis. The guidewire advanced into the
proximal artery was used for dilation of stenosis located at
the anastomosis itself or on the proximal artery. It was also
used for reopening of spasms of the artery occurring after
dilation of the vein. Balloon diameter was chosen according
to the diameter of the adjacent normal artery or vein with a
1 mm oversizing. The stenosis was then dilated with high-
pressure balloons inflated up to 25 to 30 atmospheres for a
duration of 60 to 90 seconds. Completion angiography was
conducted at the end of the procedure. No stent was ever
inserted.
Result assessment. The results were assessed on the
basis of the recommendations of the Society for Vascular
Surgery, American Association for Vascular Surgery,2 and
Society of Interventional Radiology.22
Anatomical success was defined by residual stenosis of
less than 30% on angiographic control.
Hemodynamic success was a clear improvement in flow
rate by more than 50% on Doppler ultrasound scan.
Clinical success was defined as successful use of the
vascular access after treatment for at least three dialysis
sessions.
Postoperative patency rates were evaluated and defined
according to the criteria of Sidawy et al.2 PP was defined as
the interval between the surgical or endovascular procedure
and the next intervention (as a result of restenosis or access
thrombosis). APP was defined as the interval between the
surgical or endovascular intervention and access thrombo-
sis, regardless of the number of redilations or surgical
procedures performed on still-patent fistulas. Secondary
patency was calculated when intervention was necessary
because of thrombosis.
sidua
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software package for Windows, version 11 (SPSS Inc.,
Chicago, Ill). The survival variables (PP and APP) were
presented in the form of Kaplan-Meier actuarial survival
plots. The qualitative variables were compared using the 2
test and the quantitative variables using the t test. The
survival curves were compared using the log-rank test. For
all the comparisons, the significance level was 0.05.
Multivariate analysis was conducted using a Cox model
(stepwise ascending technique) to investigate for the po-
tential existence of factors influencing the time to stenosis
recurrence after management of the perianastomotic steno-
ses. The variables studied were classified by group: (1)
epidemiological factors: patient’s home town, age, gender,
body mass index (BMI), blood pressure (130/80 in
patients with kidney failure), diabetes (fasting venous blood
glucose1.26 g/L or venous blood glucose2 g/L at any
time of the day, or medical treatment), dyslipidemia (HDL
cholesterol 0.4 g regardless of gender or medical treat-
ment), smoking (smoker or nonsmoker not having quit at
least 3 years previously), coronary artery disease, and occlu-
sive arterial disease of the legs; (2) medication liable to
prevent intimal hyperplasia: statin, platelet-aggregation in-
hibitor, oral anticoagulant, and angiotensin-converting en-
zyme inhibitor; (3) anatomical factors: age of the arterio-
venous shunt, shunt maturity (a shunt is considered
immature if it cannot be punctured 6 weeks postcreation,
or if the flow rate across the shunt is300 mL/min), flow
rate across the shunt (measured by Transonic pretreat-
ment), vein diameter and artery diameter (at the time of
stenosis), degree of stenosis, length of stenosis, and stenosis
site.
RESULTS
Population. During the study period, 73 stenosis
Fig 2. a, Peri-anastomotic stenosis confirmed by ang
balloon inflated for 65 seconds. c, No postangioplasty rewere treated: 21 by surgery and 52 by dilation. No patientwas lost to follow-up. The angioplasty and surgery groups
had similar patient characteristics (age, BMI, gender, car-
diovascular risk factors, medication liable to influence the
emergence of intimal hyperplasia; Table I). The mean age
of the patients was 70 years for the angioplasty group and
65 years for the surgery group (not significant [NS]). The
fistulas had the same characteristics at the time of stenosis
management (fistula age, vessel dimensions, and propor-
tion of mature RCFs; Table II). Seventy-three percent
of the RCFs were mature in the angioplasty group, and 66%
in the surgery group (NS). The anatomical characteristics
of the stenosis in the two groups were similar site and
length (Table III). The mean follow-up was 39 months
(SD 21) for the angioplasty group and 49months (SD
Table I. Patient characteristics
Angioplasty
n  52 (%)
Surgery
n  21 (%)
Center 1 (n  38) 30 (57) 8 (38)
Center 2 (n  35) 22 (42) 13 (61)
Age (year) 71 (SD  12) 65 (SD  19)
Gender
Male 31 (59) 13 (62)
Female 21 (41) 8 (38)
BMI (kg/m2) 27 (SD  18) 25 (SD  4)
Diabetes 22 (42) 7 (33)
Hypercholesterolemia 25 (4) 12 (57)
Hypertension 38 (73) 16 (76)
Smokinga 21 (40) 6 (28)
CAOD 17 (32) 8 (38)
PAOD 16 (30) 5 (23)
BMI, Body mass index; CAOD, coronary artery occlusive disease; PAOD,
peripheral arterial occlusive disease.
aSmoker or not having quit at least 3 years previously.
phic evaluation. b, Angioplasty: 8-mm high-pressure
l stenosis.iogra21) for the surgery group (P  .088).
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clinical success rate was 92.3% in the angioplasty group and
90.5% in the surgery group (NS). The anatomical success
rate was 75% for the angioplasty group and 85.7% for the
surgery group (NS). Surgery was associated with a mean
sacrifice of 3 cm of vein.
Radial-cephalic fistulas flow rate. The increase in
flow rate determined by the Transonic system was on
average 402 mL/min after dilation and 364 mL/min after
surgery. There was no significant between-group differ-
ence.
Restenoses. At 1 year, the restenosis rate was signifi-
cantly higher in the angioplasty group (69%) compared to
the surgery group (43%; P  .036). The time to the first
recurrence was 5.7 months (SD, 6.4) in the angioplasty
group and 12.8 months (SD, 15.5) in the surgery group
(P  .07; NS).
Restenosis gave way a total of 103 procedures: 90 in the
angioplasty group, 1.7 procedures per year (82.9% angio-
plasty treatments of the recurrences), and 13 procedures in
the surgery group, 0.6 procedures per year. All recurrences
in both groups were treated by angioplasty with the aim to
preserve enough length of vein for continued needling
(Table IV).
At the end of the study, 52 patients had a functional
RCF, 1 patient had undergone an interposition graft, 9
patients’ new autogenous fistulas had been constructed (6
Table II. RCF characteristics at time of stenosis
management (quantitative variables: mean  SD)
Angioplasty Surgery
P
valueMean SD Mean SD
RCF age at time of stenosis
(months) 12 9 10 10 .659
Pretreatment flow rate
(mL/min) 456 215 472 225 .774
RCF, Radial-cephalic fistulas.
Table III. Anatomical characteristics of the stenosis
Angioplasty Surgery
P
valuen % n %
Site .481
Anastomotic 13 25 3 15
Venous 25 48 15 70
Arterial 6 12 1 5
Mixeda 8 15 2 10
Percentage of stenosis .181
80% 31 59 16 76
80% 21 41 5 24
Length of stenosis .350
2.5 cm 21 40 11 52
2.5 cm 31 60 10 48
aStenosis site at the anastomosis and on the venous side. Association of two
or three kinds of stenoses.brachial-cephalic and 3 brachial-basilic), 1 patient was ondialysis with a central venous catheter, and 10 patients had
died. Follow-up data are summarized in Fig 3.
Complications. Two complications (3.8%) consisting
of vein rupture occurred in the angioplasty group. In these
cases, the anastomosis was immediately reconstructed after
failure of prolonged low-pressure balloon inflation. A single
complication (2.8%) was observed in the surgery group and
consisted of a minor hematoma. Central venous catheter
use was never necessary immediately after stenosis treat-
ment and all RCFs were usable within 48 hours irrespective
of procedure.
Postintervention PP. The median time to restenosis
was 6 months in the angioplasty group and 51 months in
the surgery group (Fig 3). The PP rates at 12 months were
significantly better for surgery with 71 10% compared to
41  6% for dilation (log-rank, 5.65; P  .0175).
Postintervention APP. The APP at 12 months was
92  4% in the angioplasty group and 95  4% in the
surgery group. The difference was not significant (log-rank,
0.54; P  .462; Fig 4). We found no significant difference
in PP rates or APP rates between the angioplasty group and
the surgical group specifically for patients with a stenosis
clearly confined to the vein and not involving the anasto-
mosis.
Multivariate analysis. In the population of 73 pa-
tients, two variables were independent risk factors for ste-
nosis recurrence: angioplasty (95% confidence interval [CI]
0.140-0.730; P  .007) and immature fistula (95% CI,
0.194-0.834; P  .014).
In the angioplasty group, two variables were indepen-
dent risk factors for stenosis recurrence: stenosis site at the
anastomosis itself (95% CI, 0.006-0.392; P  .005) and
smoking (95% CI, 0.164-0.804; P  .013).
DISCUSSION
This comparative nonrandomized study confirms that
surgical revision of the anastomosis in dysfunctional but
patent fistulas yields better PP rates than PTA. This was
suggested by noncomparative studies detailed in Table V.
Only one previous retrospective study compared surgery
and PTA.19 The 54% 1-year PP for angioplasty was clearly
below the 91% achieved with surgery. Our own results
(41% for PTA, 71% for surgery) look slightly lower than
those previously published, but our patients were older and
we treated higher proportions of patients with diabetes.
The principal limitation of the present study is also its
retrospective nature. Treatment was not randomized and
the treatment allocation criteria were left to the investiga-
tor’s discretion. Although not necessarily likely, at one
center where only a radiologist treated the patients, he
would be much more likely to favor repeat angioplasty for a
previously failing angioplasty, where at the other center
where the surgeon treated patients, the surgeon might
choose to allow the fistula to thrombose if previous inter-
ventions had resulted in early restenosis. In the study by
Tessitore et al,19 all the foreseeable failures were excluded
from the angioplasty group and the complex stenosis (stag-
gered, length2.5 cm, tightness90%) were significantly
atmen
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used small pieces of prostheses (3-5 cm long) for the
surgical treatment in half of the cases. In contrast, the two
groups of patients were similar in our study.
With regard to immediate outcomes, we did not find
any difference between groups in terms of increase in fistula
flow rates after procedures (determined by the Transonic
system) in clinical or in anatomical success rates. The results
are concordant with the literature.
Only one short series reported such debatable stent
placements in this location, with a poor 31% 1-year PP
rate.23
The APP study showed that there was no difference
between the two treatments: 92% for the angioplasty group
and 95% for the surgery group. In Tessitore et al’s study,19
the APP rates were also similar for the angioplasty (91%)
and surgery (97%) groups. Equivalent results have been
reported in noncontrolled series having included all types
of stenosis, perianastomotic or not, treated by sur-
gery8,10,12,14,15 or by PTA.4,5,17,18 In those series, the APP
rates ranged from 79% to 90% in the dilation group and
from 75% to 95% in the surgery group. The APP rates
Table IV. Angioplastic and surgical results (patency exclu
Clinical success
n (%)
Anatomical success
n (%)

Angioplasty 48 (92) 39 (75)
Surgery 19 (90) 18 (85)
aDifference in flow rate crossing the fistula determined by Transonic pretre
Fig 3. Postoperative primary patency rate of the 73 radial-
cephalic fistulas (RCFs): 45 events ended postintervention primary
patency (45 restenosis and 1 RCF discontinuation due to vein
rupture); 28 nonevents. TRT, treatment.reported herein are equivalent for the two treatments, butof course with a significantly higher number of repeat
procedures for the angioplasty group (1.7 procedures/year
for the angioplasty group vs 0.6 procedures/year for the
surgery group; P .07). Furthermore, a patient could have
had 10 repeated balloon angioplasties after 1 initial balloon
angioplasty and another patient could have had 1 surgical
revision after the first procedure, but the APP rate would
have been similar. Tessitore et al19 did not observe any
difference in cost, despite the larger number of repeat
procedures. Cost analysis studies are often not superimpos-
able from one country to another because their results
depend on wide variations in billing or reimbursement rates
between procedures. In our country, the cost of dilation
balloons, catheters, guidewires, contrast medium, and an-
giography suites clearly overpass the cost of the operating
room including regional anesthesia. Good APP rates are
possible using both approaches with a rigorous program to
detect complications.1,3
The present study found a significant correlation be-
ratea
in
Restenosis during the
time of study
n (%)
Reintervention
Number of procedures/year
36 (69) 1.7
9 (43) 0.6
t and posttreatment.
Fig 4. Postoperative assisted primary patency of 73 radial-
cephalic fistulas (RCFs): 10 events ended assisted postoperative
primary patency (10 discontinuations of RCF replaced by 6
brachial-cephalic RCFs and 3 brachial-basilic RCFs, 1 patient on
central venous catheter dialysis); 62 nonevents. TRT, treatment.ded)
flow
mL/m
402
364tween fistula immaturity and the risk of early recurrence.
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1-year PP between mature and immature RCFs with 56%
for mature and 46% for immature fistulas (P  .03).
In our study, multivariate analysis showed that a purely
anastomotic location of the stenosis was another factor
influencing recurrence. We considered three different types
of lesions in this series: venous, anastomotic, and arterial
stenosis. Although little, if any, literature exists distinguish-
ing these lesions, it is intuitive to surgeons who create RCFs
and maintain them that these three lesions represent differ-
ent pathologies. Arterial lesions are usually related to intrin-
sic arterial disease, usually atherosclerosis. Anastomotic ste-
noses are likely a combination of technical imperfections
and intimal hyperplasia. The venous lesions are likely accel-
erated intimal hyperplasia complicating intrinsic venous
pathology at the site of valves or related to turbulences or
mobilization trauma. Therefore, it would not be surprising
to find different outcomes in the angioplasty group of this
study, as the location of stenosis at the anastomosis was a
highly significant risk factor for early recurrence (P .005).
This finding was previously suggested by Manninen et al17
who reported lower patency rates for anastomotic com-
pared to nonanastomotic stenosis, although the difference
did not reach statistical significance.
On the basis of the study, it might now be considered
that perianastomotic stenosis, and especially those located
at the anastomosis itself, should rather undergo surgical
treatment.
However, somemarginal concerns can be raised against
surgical revision of anastomotic stenosis in some groups of
patients. For example, Turmel-Rodrigues et al24 explained
that the creation of a new and more proximal anastomosis
can potentially work so well and result in such an increase in
fistula flow rate that it might be contraindicated in cases of
poor arterial supply to the hand (elderly, diabetics, smok-
ers) and in cases of concomitant asymptomatic central vein
stenosis or occlusion. In cases of poor arterial supply to the
hand, the steal exerted by the repaired fistula can break the
previous balance between fistula flow allowing dialysis and
sufficient residual feeding flow to the fingers. In cases of
Table V. Literature: 1-year primary patency rates after
treatment of perianastomotic stenoses in nonthrombosed
RCFs
Author Technique
Primary
patency
rates (%)
Mean
patients
age (years)
Diabetics
(%)
Lipari et al25 Surgery 81 61 12
Tessitore et al19 Surgery 91 56 19
This study Surgery 71 65 33
Tessitore et al19 PTA 54 62 21
Asif et al18 PTA 47 53 32
Manninen et al17 PTA 20 59 N/A
This study PTA 41 71 42
N/A, Not available; PTA, percutaneous transluminal angioplasty; RCF,
radial-cephalic fistulas.concomitant asymptomatic central vein stenosis/occlu-sion, collaterals that were able to divert a low fistula flow
can become unable to divert the increased flow rate after
revision of the anastomosis. The third potential contraindi-
cation for creation of a new anastomosis proximal to steno-
sis located in the lower forearm is the deep location of the
vein in the predictable immediate outflow of the new
anastomosis. The benefit of simple anastomotic surgery
would be counterbalanced by the need for the surgeon to
transpose the vein of the new cannulation area beneath the
skin.
CONCLUSION
The results of this retrospective study suggest that the
treatment of perianastomotic stenosis of distal RCFs should
be surgical more than angioplasty. A significant fall in fistula
flow rate, detected through a program of blood flow sur-
veillance in dialysis or Doppler ultrasound scan, call for an
imaging (Doppler ultrasound scan or angiographic evalua-
tion) to confirm a perianastomotic stenosis and appreciate
the flow rate of the ulnar artery. These perianastomotic
stenoses can be referred directly to surgery, although PTA
remains a valuable but less durable option. Rather than
contrasting surgery and angioplasty, it can be considered
that the two techniques are complementary. The patient
should be managed by physicians able to deploy both
techniques or by a multidisciplinary team.
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